New combo treatment shows promise for slowing ALS progression
NCT ID NCT04654689
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This study tested whether a combination of curcumin and resveratrol (natural anti-inflammatory compounds) plus the drug G04CB02 can help people with ALS. 60 adults with ALS took either the treatment or a placebo for 2 months. Researchers measured muscle function, breathing, and inflammation levels to see if the treatment slowed the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
José Enrique de la Rubia Ortí
Valencia, Valencia, 46007, Spain
Conditions
Explore the condition pages connected to this study.